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Background: Increased morbidity and mortality have been associated with coronary
artery bypass grafting when an adjunctive coronary endarterectomy is performed. In
this study we retrospectively reviewed our experience with coronary bypass and
endarterectomy to evaluate the early and late outcome and to determine the inde-
pendent predictors of early mortality and morbidity of this procedure.
Methods: Between May 1989 and December 2000, 107 patients underwent myo-
cardial revascularization with coronary endarterectomy to achieve a complete re-
vascularization. There were 90 men and 17 women; the mean age was 64  8.1
years. Sixty-three (58.9%) patients had a previous myocardial infarction, and 29
(27.1%) were operated on on an emergency basis. An ejection fraction of less than
30% was present in 9 (8.4%) patients. The most frequently endarterectomized vessel
was the left coronary artery (74.8%). Follow-up information was obtained from 97
patients (100% of the long-term survivors).
Results: There were 5 (4.7%) early deaths. The 72-month survival was 91.2% 
4.9%. Seventy-seven (83.7%) of the survivors were symptom free, and 15 (16.3%)
were in Canadian Cardiovascular Society class II to III. An improvement of the
ejection fraction after the operation was shown in the 97 patients who underwent
echocardiographic control (P  .03) and angiography. The 30.4-month patency rate
of the endarteriectomized coronary arteries was 72%  11%.
Conclusion: Coronary endarterectomy is a safe and effective procedure for achiev-
ing a complete revascularization in patients with end-stage coronary disease.
In the 1950s, coronary endarterectomy (CE) was introduced as a method oftreating coronary artery disease (CAD)1 and then was adopted by severalinstitutions, mostly associated with coronary artery bypass brafting(CABG).After initial reports, CE was questioned as an effective treatment fordiffuse CAD because of increased myocardial infarction and early mortality
rates2 and was thereafter used much less frequently.
In the last 2 decades, however, increasing surgical population morbidity associ-
ated with advances in cardiac surgery and a better patient selection has prompted the
resurgence of CE. A complete revascularization showing acceptable results was then
made feasible, even in patients with end-stage CAD.3-6
In our institution CE was carried out on a small group of highly selected patients
when distal anastomosis to an adequately sized vessel was not possible.
The aim of this study was to assess, retrospectively, the early and late results of
From the Departments of Cardiovascular
Surgerya and Cardiology,b Policlinico S.
Orsola, University of Bologna, Bologna,
Italy.
Received for publication Nov 28, 2001; re-
visions requested Dec 13, 2001; revisions
received Feb 25, 2002; accepted for publi-
cation March 11, 2002.
Address for reprints: Bruno Chiappini, MD,
Department of Cardiovascular Surgery,
University of Bologna, via G. Massarenti,
9-40138 Bologna, Italy (E-mail:
bruno_chiappini@hotmail.com).
J Thorac Cardiovasc Surg 2002;124:553-60
Copyright © 2002 by The American Asso-
ciation for Thoracic Surgery
0022-5223/2002 $35.000 12/1/124670
doi:10.1067/mtc.2002.124670
Marinelli et al Surgery for Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 3 553
A
CD
CE and CABG and to determine the independent predictors
of early mortality and myocardial infarction after surgical
intervention.
Material and Methods
Patients’ Profiles
Between May 1989 and December 2000, 107 patients underwent
myocardial revascularization with CE at the University of Bologna
to achieve a complete revascularization. There were 90 (84.1%)
men and 17 (15.9%) women, with a mean age of 64  8.1 years
(range, 41-81 years). Fifty (46.7%) patients had a previous history
of smoking; hypertension was present in 49 (45.8%) patients, and
previous myocardial infarction had been experienced in 63
(58.9%). Unstable angina was present in 54 (50.5%) patients.
Twenty-nine (27.1%) patients were operated on as an emergency.
Impairment of the ventricular function (ejection fraction [EF]
30%) was present in 9 (8.4%) patients. Three (2.8%) patients had
undergone a previous myocardial revascularization (Table 1).
All procedures were performed with extracorporeal circulation
and moderate hypothermia (31°C); myocardial protection was
obtained by means of intermittent antegrade crystalloid cardiople-
gia (St Thomas Hospital Solution) and topical cooling with cold
saline (4°C). An endarterectomy was performed by using a manual
technique7 and, for the most part, was performed on occluded
(65.4%) vessels in the preoperative coronary angiogram. As much
plaque as possible was removed, typically between 4 and 10 cm. If
residual plaque was thought to remain in the distal vessel, the
arteriotomy was enlarged as much as necessary to allow complete
removal of the plaque, especially on the left anterior descending
artery (LAD). The endarteriectomized vessels were flushed with
heparinized solution to remove small residual particles. When a
CE was performed on the LAD, the internal thoracic artery was
sewn to a saphenous vein patch, which was used to reconstruct the
vessel in all cases. A saphenous vein graft was used as a conduit
to the arteriectomy site in the other vessels.
A CE was performed in a single vessel for each patient on the
arteries having a diameter of greater than 1.5 mm; the vessels were
the left coronary artery in 80 (74.8%), the right coronary artery in
8 (7.5%), the descending posterior artery in 8 (7.5%), the obtuse
marginal artery in 7 (6.5%), and the diagonal artery in 4 (3.7%)
patients.
The mean extracorporeal circulation and aortic crossclamp
times were 124  43 minutes (minimum, 60 minutes; maxi-
mum, 400 minutes) and 80  25 minutes (minimum, 28 min-
utes; maximum, 165 minutes), respectively. The associated
procedures were aortic valve replacement in 5 (4.7%), mitral
valve replacement in 4 (3.7%), left ventricular aneurysmectomy
in 2 (1.9%), and ascending aorta replacement in 2 (1.9%)
patients (Table 2).
Patients were anticoagulated postoperatively. Low-molecular-
weight heparin was initiated 6 hours after arrival in the intensive
care unit. After 2 days, this was replaced by warfarin sodium for
the following 6 months, maintaining an international normalized
ratio of 2.0 to 2.5. Then aspirin (300 mg/d) was initiated and
continued indefinitely.
Data Collection
The medical records of all patients were retrospectively reviewed.
The data collected included the following: (1) demographics; (2)
comorbidity risk factors; (3) operative data; (4) mortality; and (5)
postoperative complications defined as myocardial infarction (new
Q-wave or loss of R-wave progression across the chest leads;
creatine kinase MB 10%), low cardiac output (a newly placed
intra-aortic balloon pump [IABP] or the use of inotropes for 48
hours), malignant ventricular arrhythmias, bleeding requiring a
rethoracotomy, stroke, respiratory insufficiency (mechanical ven-
tilatory support 48 hours), renal failure requiring dialysis, and
mediastinal infection.
Follow-Up
A questionnaire was administered to the patients included in the
study investigating survival, symptoms, long-term medical man-
agement, readmissions and reinterventions, and any surgery-re-
Figure 1. Actuarial survivals after CABG and CE. Operative and late deaths are included.
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lated complications. A series of 97 patients underwent echocar-
diographic examination and angiographic control.
Statistical Analysis
Statistical analysis was performed by using SPSS 7.0 statistical
software (SPSS Inc, Chicago, Ill). Continuous variables were
expressed as mean 1 SD, and categoric variables were expressed
as percentages. All variables were first analyzed with univariate
analysis (impaired 2-tailed t test, 2 test, or Fisher exact test when
appropriate) to determine whether any single factor influenced
hospital mortality and postoperative myocardial infarction. Vari-
ables that achieved P values of less than .05 in the univariate
analysis were examined with multivariate analysis by means of
forward stepwise logistic regression to evaluate independent risk
factors for hospital mortality and myocardial infarction after sur-
gical intervention.
Survival data were analyzed by using the standard Kaplan-
Mayer actuarial technique for estimation of survival probabilities.
Results
Early Outcome
Five (4.7%) patients died during hospitalization as a result
of multiorgan failure (n  1), ventricular fibrillation (n 
2), and low cardiac output (n  2). Of these 5 patients, 4
were preoperatively critical and operated on as an emer-
gency.
The first patient was a 70-year-old man operated on as a
result of a severe acute ischemic mitral insufficiency and
treated with CABG and mitral anuloplasty. The CE was
performed on the right coronary artery supplying an already
infarcted territory. Despite high inotropic support and tem-
porary mechanical circulatory support with IABP, he died
as a result of low cardiac output 3 days after the operation.
The second patient was an 80-year-old man with unstable
angina and preoperative renal failure requiring dialysis. A
stroke occurred postoperatively, and multiorgan failure was
TABLE 1. Demographic characteristics
Variables Patients (n) Patients (%)
Sex
Male 90 84.1
Female 17 15.9
Age (y) 64 8.1
Hypertension
Yes 49 45.8
No 58 54.2
Smoking
Yes 50 46.7
No 57 53.3
Family history
Yes 43 40.2
No 64 59.8
Diabetes
Yes 22 20.6
No 85 79.4
Hyperlipidemia
Yes 43 40.2
No 64 59.8
Previous myocardial infarction
Yes 63 58.9
No 44 41.1
Previous stroke
Yes 6 5.6
No 101 94.4
Aortic valve disease
Yes 6 5.6
No 101 94.4
Mitral valve disease
Yes 4 3.7
No 103 96.3
Left ventricular aneurysm
Yes 2 1.9
No 105 98.1
Unstable angina
Yes 54 50.5
No 53 49.5
EF 30%
Yes 9 8.4
No 98 91.6
NYHA
I 1 0.9
II 33 30.8
III 54 53.3
IV 14 15
Status
Elective 78 72.9
Urgent 29 27.1
COPD
Yes 17 15.9
No 90 84.1
Chronic renal failure
Yes 4 3.7
No 103 96.3
Previous CABG
Yes 3 2.8
No 104 97.2
Continuous data are expressed as mean  1 SD. COPD, Chronic obstruc-
tive pulmonary disease.
TABLE 2. Operative characteristics
Variables Patients (n) Patients (%)
AVR
Yes 5 4.7
No 102 95.3
MVR
Yes 4 3.7
No 103 96.3
Ventricular aneurysmectomy
Yes 2 1.9
No 105 98.1
CE on nonoccluded vessel
Yes 70 65.4
No 37 34.6
CPB time (min) 124 43
Aortic crossclamp time (min) 80 25
AVR, Aortic valve replacement; MVR, mitral valve replacement; CPB,
cardiopulmonary bypass.
Marinelli et al Surgery for Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 3 555
A
CD
the cause of death. The last 2 patients had associated valve
surgery (one of them had an EF of 30%). In these cases
death was caused by postoperative ventricular fibrillation
and the impossibility of completing cardiopulmonary by-
pass (Table 3).
On univariate analysis, the following factors had a sig-
nificant influence on hospital mortality: advanced age (P 
.026), history of smoking (P  .032), chronic renal failure
(P .001), unstable angina (P .023), mitral valve disease
(P  .001), prolonged cardiopulmonary bypass time (P 
.001), mitral valve replacement (P  .001), postoperative
hemodynamic instability (P  .016), postoperative acute
renal failure (P  .001), postoperative respiratory insuffi-
ciency (P  .002), and ventricular fibrillation (P  .001;
Table 4). Multivariate analysis revealed unstable angina
(odds ratio [OR] 7.3, P .006), mitral valve replacement
(OR  9.1, P  .002), and ventricular fibrillation (OR 
5.2, P  .021) to be independent predictors of hospital
mortality (Table 5).
Postoperative myocardial infarction occurred in 2 (1.9%)
patients. Postoperative hemodynamic instability was ob-
served in 10 (9.3%) patients, and 6 (5.6%) patients were
treated with IABP. Ventricular fibrillation occurred in 4
(3.7%) patients, causing death in 2. The independent pre-
dictors of increased myocardial infarction rate, assessed by
means of univariate analysis, were aortic valve replacement
(P  .002), prolonged cardiopulmonary bypass (P  .04),
and crossclamp times (P  .019; Table 6). In the multivar-
iate analysis aortic valve replacement remained the only
independent predictor of myocardial infarction (Table 7).
Other postoperative complications were atrial fibrillation
(21.5%), renal failure (3.7%), acute respiratory failure
(1.9%), bleeding (1.9%), and mediastinal infection (0.9%).
Late Outcome
Follow-up was 95.3% complete. The overall survival curve
is depicted in Figure 1. The 72-month survival was 91.2%
 4.9%.
During a mean follow-up period of 38.03 24.5 months
(range, 1-124.4 months), there was a total of 5 deaths: 2
patients died from primary cardiac failure, 2 from malig-
nancy, and 1 from a cerebrovascular problem. Seventy-
seven (83.7%) patients were angina free; 15 (16.3%) had
angina (12 in Canadian Cardiovascular Society class 2, 1 in
class 3, and 2 in class 4). Thirty-two (34.8%) patients was
classified as being in New York Heart Association (NYHA)
II, 10 (10.9%) in NYHA III, and 1 (1.1%) in NYHA IV.
Myocardial infarction occurred in 2 (2.2%) patients. Ninety-
seven (100%) patients underwent echocardiographic con-
trol, which showed an EF improvement after surgical inter-
vention (49.8%  8.8% vs 56.1%  14.1% mean EF, P 
.03). They underwent angiographic control at a mean period
of 30.4  16 months after surgical intervention, and the
patency rate for the endarterectomized coronary arteries was
72%  11%. The patency rate for bypass grafts to non-
endarterectomized coronary arteries was 73%  12%,
which is not different significantly from that of the endar-
terectomy grafts. According to the endarterectomized arter-
ies and bypass grafts used, the patency rates were 75% for
the LAD (internal thoracic artery graft), 90% for the RCA
(saphenous vein graft), 80% for the descending posterior
artery (saphenous vein graft), 60% for the obtuse marginal
artery (saphenous vein graft), and 55% for the diagonal
artery (saphenous vein graft).
Discussion
The completeness of revascularization has been shown to
correlate with improved early and late patient outcomes
after CABG.8-11 Currently, in patients with end-stage coro-
nary atherosclerosis, the options available include perform-
ing CABG to small distal vessels not performing any bypass
to the diseased coronary territory or using CE as an adjunc-
tive tool to CABG to achieve a complete revascularization.
However, CE is reported as a time-consuming and challeng-
ing procedure, and its beneficial effect has been questioned
because an increased risk of perioperative mortality and
TABLE 3. Postoperative results
Variables Patients (n) Patients (%)
Acute myocardial infarction
Yes 2 1.9
No 105 98.1
Hemodynamic instability
Yes 10 9.3
No 97 90.7
IABP
Yes 6 5.6
No 101 94.4
Ventricular fibrillation
Yes 4 3.7
No 103 96.3
Stroke
Yes 1 0.9
No 106 99.1
Atrial fibrillation
Yes 23 21.5
No 84 78.2
Renal failure
Yes 4 3.7
No 103 96.3
Respiratory failure
Yes 2 1.9
No 105 98.1
Bleeding
Yes 2 1.9
No 105 98.1
Mediastinal infection
Yes 1 0.9
No 106 99.1
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TABLE 4. Univariate analysis of hospital mortality
Variables
Death
P valuen %
Sex
Male 3 3.3 NS
Female 2 2.8
Age (y) 67.4 10.2 .026
Hypertension
Yes 2 4 NS
No 3 5.1
Smoking
Yes 5 8.8 .032
No — —
Family history
Yes 1 2.3 NS
No 4 6.3
Diabetes
Yes 1 4.5 NS
No 4 4.7
Hyperlipidemia
Yes 2 4.7 NS
No 3 4.7
Previous myocardial infarction
Yes 2 3.2 NS
No 3 6.8
Previous stroke
Yes — — NS
No 5 5
Aortic valve disease
Yes 1 16.7 NS
No 4 4
Mitral valve disease
Yes 2 5 .000
No 3 2.9
Left ventricular aneurysm
Yes — — NS
No 5 4.8
Unstable angina
Yes 5 9.3 .023
No — —
EF 30%
Yes — — NS
No 5 5.1
NYHA
I — — NS
II — —
III 3 5.3
IV 2 12.5
Status
Elective 2 2.6 NS
Urgent 3 10.3
COPD
Yes — — NS
No 5 5.6
Chronic renal failure
Yes 2 50 .000
No 3 2.9
Previous CABG
Yes — — NS
No 5 4.8
(continued)
TABLE 4 —Cont’d.
Variables
Death
P valuen %
AVR
Yes 1 20 NS
No 4 3.9
MVR
Yes 2 50 .000
No 3 2.9
Ventricular Aneurismectomy
Yes — — NS
No 5 4.8
CE on non-occluded vessel
Yes 4 5.7 NS
No 1 2.7
Acute myocardial infarction
Yes — — NS
No 5 4.8
Hemodynamic instability
Yes 2 20 .016
No 3 3.1
CPB time (min) 204 132 .000
Aortic crossclamp time (min) 91 38 NS
IABP
Yes 1 16.7 NS
No 4 4
Ventricular fibrillation
Yes 2 50 .000
No 3 2.9
Stroke
Yes 1 100 NS
No 4 3.8
Atrial fibrillation
Yes 2 8.7 NS
No 3 3.6
Renal failure
Yes 2 50 .000
No 3 2.9
Respiratory failure
Yes 1 50 .002
No 4 3.8
Bleeding
Yes — — NS
No 5 4.8
Mediastinal infection
Yes — — NS
No 5 4.7
Continuous data are expressed as mean  1 SD. NS, Not significant;
COPD, chronic obstructive pulmonary disease; AVR, aortic valve replace-
ment; MVR, mitral valve replacement CPB, cardiopulmonary bypass.
TABLE 5. Multivariate analysis of Hospital mortality
Variables OR P value
Unstable angina 7.35 .006
Mitral valve replacement 9.18 .002
Postoperative VF 5.2 .021
VF, Ventricular fibrillation.
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morbidity often accompanies this technique, especially
when performed on the LAD.2-5,12,13
Contrary to institutions5,6,14 in which CE is performed in
a relatively high percentage (20%-50%) of cases, we limited
this procedure to a small group of patients (3.7% of the
TABLE 6. Univariate analysis of postoperative myocardial
infarction
Variables
Myocardial
infarction
P valuen %
Sex
Male 2 2.2 NS
Female — — —
Age (y) 67.5 NS
Hypertension
Yes — — NS
No 2 3.4
Smoking
Yes — — NS
No 2 4
Family history
Yes 2 4.7 NS
No — —
Diabetes
Yes — — NS
No 2 2.4
Hyperlipidemia
Yes 1 2.3 NS
No — —
Previous myocardial infarction
Yes 1 1.6 1.6
No — —
Previous stroke
Yes — — NS
No 2 2
Aortic valve disease
Yes 1 16.7 .006
No 1 1
Mitral valve disease
Yes — — NS
No 2 1.9
Left ventricular aneurysm
Yes — — NS
No 2 1.9
Unstable angina
Yes 1 1.9 NS
No 1 1.9 NS
EF 30%
Yes — — NS
No 2 2
NYHA
I — — NS
II 1 3
III 1 1.8
IV — —
Status
Elective — — NS
Urgent 2 2.6
COPD
Yes — — NS
No 2 2.2
Chronic renal failure
Yes — — NS
No 2 1.9
(continued)
TABLE 6 —Cont’d.
Variables
Myocardial
infarction
P valuen %
Previous CABG
Yes — — NS
No 2 1.9
AVR
Yes 1 20 .002
No 1 1
MVR
Yes — — NS
No 2 1.9
Ventricular aneurismectomy
Yes — — NS
No 2 1.9
CE on nonoccluded vessel
Yes 1 1.4 NS
No 1 2.7
CPB time (min) 151 .04
Aortic crossclamp time (min) 106 .019
Acute myocardial infarction
Yes — — —
No — — —
Hemodynamic instability
Yes 1 10 .046
No 1 1
IABP
Yes 1 16.7 .006
No 1 1
Ventricular fibrillation
Yes — — NS
NO 2 1.9
Stroke
Yes — — NS
No 2 1.9
Atrial fibrillation
Yes — — NS
No 2 2.4
Renal failure
Yes — — NS
No 2 1.9
Respiratory failure
Yes — — NS
No 2 1.9
Bleeding
Yes — — NS
No 2 1.9
Mediastinal infection
Yes — — NS
No 2 .006
Continuous data are expressed as a mean  1 SD. NS, Not significant;
COPD, chronic obstructive pulmonary disease; AVR, aortic valve replace-
ment; MVR, mitral valve replacement; CPB, cardiopulmonary bypass.AVR
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patients with CAD) with severely stenosed or totally oc-
cluded arteries having a diameter of greater than 1 mm, in
which a complete revascularization would have been oth-
erwise impossible. There is a wide variation in the reported
results of CE in conjunction with CABG.
Brenowitz and colleagues5 reported a 30-day mortality of
6.3% for patients with a single endarterectomy. Livesay and
colleagues4 reported an early mortality rate of 4.4% in a
group of 3369 patients in whom the right coronary artery
was the most common site (83%) requiring CE.
In our series 5 (4.7%) hospital deaths occurred. Of these,
4 patients were preoperatively critical and operated on on an
emergency basis. We performed one endarterectomy for
each patient. The most frequently endarterectomized vessel
was the left coronary artery (74.8%). Initially, endarterec-
tomy of the right system was preferred because of its
technical simplicity and a lower risk. Brenowitz and col-
leagues5 reported a mortality rate of 4.8% for the isolated
right CE and 7.9% for the LAD. Livesay and coworkers4
reported a significantly increased early mortality rate (8.5%)
when CE was performed on the LAD, as compared with
endarterectomy of vessels other than the LAD. In our ex-
perience no hospital deaths or postoperative myocardial
infarctions occurred in this group of patients.
Using multivariate analysis, mitral valve replacement
(P  .002) and unstable angina (P  .006) were the most
important independent predictors of early mortality, proba-
bly reflecting the critical status of these patients and the
necessity for prolonged cardiopulmonary bypass and aortic
crossclamp times. In this series the mean cardiopulmonary
bypass and aortic crossclamp times were 124  43 and
80  25 minutes, respectively.
Myocardial infarction resulting from thrombosis or re-
sidual obstruction of the vessel is reported as the main cause
of postoperative morbidity and mortality. In the literature
the postoperative myocardial infarction rate ranges from 5%
to 25%, with mortality rates of 0% to 15%.8-12 In our
experience 2 postoperative myocardial infarctions occurred,
and the rate was 1.9%. Multivariate analysis revealed aortic
valve replacement (P  .02) as an independent predictor of
postoperative infarction. Interestingly, performing a CE on
a nonoccluded vessel was not indicated as a risk factor for
a myocardial infarction.
Continuous data are expressed as a mean  1 SD. NS,
Not significant; COPD, chronic obstructive pulmonary dis-
ease; AVR, aortic valve replacement; MVR, mitral valve
replacement; CPB, cardiopulmonary bypass.The 6-year ac-
tuarial survival was 91.2%  4.9%. This compares favor-
ably with the rate in other studies, typically ranging from
75% and 90%.4,5,15
Clinically, 83.7% of our survivors were angina free at an
average interval of 33.4  20.2 months after surgical inter-
vention. An improvement of myocardial contractility after
surgical intervention was also shown by means of echocar-
diographic control. At angiography, the patency rate of the
grafts anastomosed to the endarterectomized vessels was
72%  11% at a mean follow-up period of 30.4  16
months and is similar to that seen in previously published
studies.13-15 In conclusion, our data show that CE is a safe
and effective procedure for a complete revascularization in
patients with end-stage CAD and shows acceptable early
and late results.
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Appendix.
Factors assessed for hospital mortality and postoperative myocar-
dial infarction
● Sex
● Age
● Hypertension
● Smoking
● Family history
● Diabetes
● Hyperlipidemia
● Previous myocardial infarction
● Previous stroke
● Aortic valve disease
● Mitral valve disease
● Left ventricular aneurysm
● Unstable angina
● EF 30%
● NYHA class
● Status
● Chronic obstructive pulmonary disease
● Chronic renal failure
● Previous CABG
● Aortic valve replacement
● Mitral valve replacement
● Ventricular aneurismectomy
● CE on nonoccluded vessel
● Cardiopulmonary bypass time
● Aortic crossclamp time
● Acute myocardial infarction
● Hemodynamic instability
● IABP
● Ventricular fibrillation
● Stroke
● Atrial fibrillation
● Renal failure
● Respiratory failure
● Bleeding
● Mediastinal infection
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